Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQL Catheters for Elective Caesarean Section
NCT03663478Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Zealand University Hospital. Started Sep 2018; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03663478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663478.